Forest Laboratories Inc (FRX) financial statements (2020 and earlier)

Company profile

Business Address 909 THIRD AVENUE
NEW YORK, NY 10022
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2014
3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,1531,675
Cash and cash equivalents1,780936
Short-term investments373739
Receivables(2)(2)
Inventory, net of allowances, customer advances and progress billings613394
Inventory613394
Prepaid expense468
Other current assets 135
Other undisclosed current assets892746
Total current assets:4,1242,948
Noncurrent Assets
Property, plant and equipment372377
Long-term investments and receivables1,1701,349
Long-term investments1,1701,349
Intangible assets, net (including goodwill)6,2092,841
Goodwill1,049713
Intangible assets, net (excluding goodwill)5,1612,128
Other noncurrent assets142115
Total noncurrent assets:7,8944,682
TOTAL ASSETS:12,0187,630
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7221,180
Accounts payable221157
Accrued liabilities1,290840
Employee-related liabilities212182
Other undisclosed current liabilities(212)(182)
Total current liabilities:1,511998
Noncurrent Liabilities
Liabilities, other than long-term debt1,341851
Deferred tax liabilities, net740283
Liability for uncertainty in income taxes531567
Other liabilities70 
Other undisclosed noncurrent liabilities3,00036
Total noncurrent liabilities:4,341887
Total liabilities:5,8521,884
Stockholders' equity
Stockholders' equity attributable to parent6,1665,745
Common stock4443
Treasury stock, value(5,172)(5,162)
Additional paid in capital2,0611,799
Accumulated other comprehensive income1210
Retained earnings9,2219,055
Total stockholders' equity:6,1665,745
TOTAL LIABILITIES AND EQUITY:12,0187,630

Income statement (P&L) ($ in millions)

3/31/2014
3/31/2013
Revenues3,6473,126
Revenue, net3,6473,094
Cost of revenue
(Cost of Goods and Services Sold)
(761)(649)
Gross profit:2,8862,477
Operating expenses(2,775)(2,622)
Operating income (loss):112(145)
Nonoperating income (expense)(30)32
Investment income, nonoperating 29
Other undisclosed income from continuing operations before equity method investments, income taxes 68
Income (loss) from continuing operations before income taxes:82(45)
Income tax benefit8413
Net income (loss) available to common stockholders, diluted:165(32)

Comprehensive Income ($ in millions)

3/31/2014
3/31/2013
Net income (loss):165(32)
Other comprehensive income213
Comprehensive income (loss), net of tax, attributable to parent:167(19)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: